Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC and IP Chemotherapy for Recurrent Ovarian Cancer
NCT01659554Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Mar 2012
- Primary completion
- Apr 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin in ovarian cancer, primary peritoneal carcinoma (PPC), fallopian tube cancer (PFTC), sponsored by Columbia University. Started Mar 2012; status: terminated.
02
Drugs
cisplatindoxorubicin
03
Conditions
ovarian cancerprimary peritoneal carcinoma (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT01659554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01659554.